Research & Development



  雲瑯笑道︰“早點睡吧,明日,墨家人就會到來,上林署的人也會到來,我們要丈量出三千畝土地,恐怕這不是一天兩天就能完成的事情。”   這兩種東西確實能夠制造出辣味來,可是,跟雲瑯想要的復合辣味相去甚遠。嗯学姐好紧校园春色   長平的眉頭微微皺一下,旋即平復如初。亚洲校园春色综合100   雲瑯自己也吃了很多,丟下飯碗道︰“以後盡量不要吃蘑菇,這東西弄不好就會讓我們中毒。”   不過,這一點可以從沈括,黃道婆的歷史地位上就能窺出一斑。狠狠干   水槽的盡頭,還有一個類似千斤閘的裝置,用絞盤固定,不論是提升千斤閘,還是放下,都很方便。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo